# Trade Mark Journal No.2025/041 10 October 2025

## WO0000001876993 (35,36,42)

Office of origin: United States of America

Date of International Registration:30 July 2025
Date of designation in the UK: 30 July 2025

The mark consists of a depiction of the upper right quadrant of an XY chart having a vertical axis line, a horizontal axis line, and three lines extending angularly from the junction of the vertical and horizontal axis lines. There are three dots along each axis line, a dot at the junction of the axis lines, and a dot terminating each of the three lines extending angularly from the junction of the vertical and horizontal axis lines. A first U-shaped symbol is positioned to the left of the vertical axis line, and a second U-shaped symbol is positioned below the horizontal axis line.

International priority date claimed: 30 January 2025 (United States of America) (99023172)

Class 35
  Charitable services, namely, promoting public awareness of the need for access to pharmaceuticals; charitable services, namely, promoting public awareness of the need for equitable access to generic drugs for other disease.
Class 36
  Charitable fundraising services.
Class 42
  Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting services in the field of pharmaceutical research; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; laboratory research in the field of using data to identify potential other uses for generic drugs; scientific study and research in the field (s) of alternative uses for pharmaceuticals.

EVERY CURE, INC.

Representative: Scott W. Smilie, 200 South Wacker Drive, Suite 2700, Chicago IL 60606, UNITED STATES OF AMERICA